Li Zhi, Yao Shanglong, Cheng Minghua, Chen Jianyan
Shantou University Medical College, Shantou, China.
Department of Anesthesiology, Second People's Hospital of Futian District, Shenzhen, China.
Iran J Pharm Res. 2021 Spring;20(2):515-522. doi: 10.22037/ijpr.2020.113576.14381.
Postoperative cognitive dysfunction is a common postoperative neurological complication in elderly patients, and has some relationship with neuroinflammation. some studies have shown ability of dexmedetomidine to improve cognitive performance in elderly individuals who underwent thoracic surgery. Therefore, our study hypothesized that dexmedetomidine treatment may reduce the incidence of POCD in elderly patients.In addition,this study detected the antineuroinflammatory effects of dexmedetomidine by β-amyloid aggregation inhibitors and release of cytokines in elderly patients . The results show that dexmedetomidine used during operation can inhibit the postoperative release of Aβ and cytokines in elderly patients, and dexmedetomidine used during operation can reduce the incidence of postoperative cognitive dysfunction, with dose-dependence. These results provide a clinical application direction for clinical anesthesiologists and ICU physicians.
术后认知功能障碍是老年患者常见的术后神经并发症,与神经炎症有一定关系。一些研究表明右美托咪定能够改善接受胸外科手术老年患者的认知表现。因此,我们的研究假设右美托咪定治疗可能降低老年患者术后认知功能障碍的发生率。此外,本研究通过β-淀粉样蛋白聚集抑制剂和老年患者细胞因子释放来检测右美托咪定的抗神经炎症作用。结果表明,术中使用右美托咪定可抑制老年患者术后Aβ和细胞因子的释放,且术中使用右美托咪定可降低术后认知功能障碍的发生率,具有剂量依赖性。这些结果为临床麻醉医生和重症监护病房医生提供了临床应用方向。